Navigation Links
DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Date:3/19/2013

New York, NY (PRWEB) March 19, 2013

The prescription drug resource center DrugRisk.com is alerting patients who have taken the drug Actos of updated legal news on the site. The resource site learned this week of new evidence showing the manufacturer may have known of the risks of bladder cancer in 2003, but did nothing to warn patients.

“The goal of DrugRisk is to improve consumer safety by publishing the latest drug warnings, recalls, studies and litigation news. Informed patients can discuss options with their doctor and decide if they need legal advice,” explains DrugRisk representative Ryan Mayer.

The resource center contains Actos warnings from both the FDA* and European Medicines Agency** who indicated that long-term use of the drug may be associated with an increased risk of bladder cancer. The drug has also been banned in France and Germany.***

In legal news, Takeda, the maker of Actos faces as many as 3,000 claims over Actos bladder cancer.**** More than 1,200 patients have filed an Actos lawsuit against the drug maker in a special multi-district federal court in Louisiana.***** Other cases have been filed in California.****

The first Actos trial began this month in California. Now, DrugRisk has learned that lawyers representing a man dying of cancer in that trial filed a study on January 25th which shows Takeda asked doctors in 2003 if they would still prescribe a diabetes drug that had bladder cancer risks. However, they didn’t disclose their concerns to patients.****

Lawyers are still helping those affected file claims. Anyone diagnosed with bladder cancer after taking Actos is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of defective drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.

For more information on the research, side effects, litigation news and a potential Actos recall or to speak with a lawyer, visit http://www.DrugRisk.com.

*fda.gov/ForConsumers/ConsumerUpdates/ucm263431.htm#Actos
**http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/07/news_detail_001311.jsp&mid=WC0b01ac058004d5c1
***cbsnews.com/8301-504763_162-20070492-10391704.html
****businessweek.com/news/2013-02-15/takeda-worried-about-actos-s-cancer-link-filing-shows
***** In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).

Read the full story at http://www.prweb.com/releases/actos-recall/actos-lawsuits/prweb10491110.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
2. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
3. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
4. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
5. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
6. DrugRisk Announces New Pradaxa Health Warning From Australia
7. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
8. DrugRisk Announces Updated Information on Mirena Lawsuits
9. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
10. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
11. Update: Number of Stryker Rejuvenate Hip Recall Lawsuits Growing in New Jersey Multicounty Litigation, Announces Wright & Schulte LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Francisco, CA (PRWEB) , ... February 08, 2016 , ... ... raise $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently retired ... also was the American Cancer Society’s 2015 CEO of the Year , helped ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... of organizations. DocuSyst provides a cloud hosted environment for FileHold software that ... integration with various 3rd party applications using the FileHold web services API. DocuSyst ...
(Date:2/8/2016)... ... February 08, 2016 , ... TopConsumerReviews.com recently awarded their ... removal products. , Moles are derived from a cluster of melanin when exposed to ... wrong places and create a lifetime of embarrassment. Historically, mole removal has ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to ... the U.S. require dental technicians to be certified or obtain continuing education. To ... created the “What’s In Your Mouth?” campaign to inform dentists and patients about ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... has added Kybella® to his medical and surgical expertise. Technically known as deoxycholic ... injectable medication used as a non-surgical alternative for reduction of fat below the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... --  Intarcia Therapeutics, Inc. today announced the appointment ... newly created role of Vice President, Head of Global ... decades of leadership experience at leading pharmaceutical, biotechnology, and ... center. Most recently Dr. Yee served as VP, Head ... Medical Officer at AstraZeneca, where he led medical affairs ...
(Date:2/8/2016)... 8, 2016 /PRNewswire/--  Cell Applications, Inc. and ... services are now available in North ... (3D) bioprinting approach called the "Kenzan Method." Utilizing ... a state-of-the-art robotic system that fabricates 3D tissue ... pay-for-service bio-printing model that makes scaffold-free tissue available ...
(Date:2/8/2016)... -- Velano Vascular, a medical technology company transforming and ... practitioners, announced today that the company has raised an ... proceeds from this financing, an extension of a $5 ... support the development and commercialization of the company,s inpatient ... Philadelphia , and a number of ...
Breaking Medicine Technology: